PHARMAESSENTIA CORP.
Area: Pharmaceutical and Medical Devices
Booth No:
M220
Website: https://hq.pharmaessentia.com/tw
Exhibitor Profile
PharmaEssentia creates a novel product- Ropeginterferon alfa-2b, which is the long-acting, mono-pegylated proline interferon with improved pharmacokinetic properties allowing once every two weeks administration offering improved tolerability and convenience. The marketing authorization for Ropeginterferon alfa-2b for treatment of Polycythemia Vera (PV) is granted by EMA, Taiwan, Korea, US, Japan, Singapore, Malaysia, China and Brazil.
Brands
Ropeginterferon alfa-2b
Video
-
PharmaEssentia - Improving Treatments, Improving Lives
Exhibit Products
Exhibitors you may be interested in
Highest Rated
-
MICRODOCTOR BIOMEDICAL CORPORATION
-
MINOGA INDUSTRIAL CO., LTD.
-
AEPROMED INNOVATION CORP., LTD.
-
NATIONAL HEALTH RESEARCH INSTITUTES
-
PHARMAESSENTIA CORP.
-
WCC BIOMEDICAL CO., LTD.
-
BIOMEDICAL TRANSLATION RESEARCH CENTER, ACADEMIA SINICA (NATIONAL BIOTECHNOLOGY RESEARCH PARK)
-
YENCHEN MACHINERY CO., LTD.
-
GOLDEN BIOTECHNOLOGY CORP.
-
TAIWAN BIO-MANUFACTURING CORPORATION
-
STELLARCELL BIOMEDICINE INC.
-
MYCENAX BIOTECH INC.
-
SPIRIT SCIENTIFIC CO. LTD.
-
BIOTOOLS CO., LTD.
-
YANG MING REGENERATIVE THERAPEUTICS CO.
-
ADIMMUNE CORPORATION
-
IVD R.E.D. MICROFLUIDIC CHIP SERVICE & SUPPORT CORPORATION
-
CHINA MEDICAL UNIVERSITY
-
NATIONAL SCIENCE AND TECHNOLOGY COUNCIL
-
NCHU SCIENTIFIC RESEARCH PLATFORM FOR INDUSTRIALIZATION
-
UTEK INTERNATIONAL CORPRATION
-
MITEKLAB CO., LTD.
-
MYCOMAGIC BIOTECHNOLOGY CO., LTD.
-
LEVEL BIOTECHNOLOGY INC.
-
DEVELOPMENT CENTER FOR BIOTECHNOLOGY
-
BORA PHARMACEUTICALS CO., LTD.
-
TAIMED BIOLOGICS INC.
-
EFFICIENT PHARMA MANAGEMENT CORP.
-
NECKAR CO., LTD.
-
AMAREX TAIWAN, LLC
back